Lite Strategy, Inc. (LITS)
NASDAQ: LITS · Real-Time Price · USD
1.670
-0.080 (-4.57%)
At close: Dec 5, 2025, 4:00 PM EST
1.736
+0.066 (3.93%)
After-hours: Dec 5, 2025, 6:56 PM EST
Company Description
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of novel and differentiated therapies for the treatment of cancer.
The company was formerly known as MEI Pharma, Inc. and changed its name to Lite Strategy, Inc. in September 2025.
Lite Strategy, Inc. was incorporated in 2000 and is based in San Diego, California.
Lite Strategy, Inc.
| Country | United States |
| Founded | 2000 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 4 |
| CEO | Justin File |
Contact Details
Address: 9920 Pacific Heights Blvd., Suite 150 San Diego, California 92121 United States | |
| Phone | 858 369 7100 |
| Website | litestrategy.com |
Stock Details
| Ticker Symbol | LITS |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0001262104 |
| CUSIP Number | 55279B301 |
| ISIN Number | US55279B3015 |
Key Executives
| Name | Position |
|---|---|
| Justin J. File CPA | Acting Chief Executive Officer, Chief Financial Officer and Corporate Secretary |
| Anne Frese | Chief People Officer |
| Dr. Robert D. Mass M.D. | Strategic Advisor |